0001237899-20-000029.txt : 20200708
0001237899-20-000029.hdr.sgml : 20200708
20200708161600
ACCESSION NUMBER: 0001237899-20-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200707
FILED AS OF DATE: 20200708
DATE AS OF CHANGE: 20200708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SING GEORGE L
CENTRAL INDEX KEY: 0001225471
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 201018548
MAIL ADDRESS:
STREET 1: LANCET CAPITAL
STREET 2: 45 ROCKEFELLER PLAZA STE 2008
CITY: NEW YORK
STATE: NY
ZIP: 10111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-07-07
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001225471
SING GEORGE L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2020-07-07
4
M
0
7500
33.42
A
122915
D
Common Stock
2020-07-07
4
S
0
7500
650.0
D
115415
D
Common Stock
2020-07-07
4
S
0
500
650.0
D
1150
I
by Spouse
Common Stock
2020-07-07
4
S
0
800
650.32
D
600
I
by Spouse/Cust Son
Common Stock
2020-07-07
4
S
0
200
651.09
D
400
I
by Spouse/Cust Son
Common Stock
2020-07-07
4
S
0
1500
650.0
D
4700
I
by Trust for Son
Non-Qualified Stock Option (right to buy)
33.42
2020-07-07
4
M
0
7500
0.0
D
2021-01-03
Common Stock
7500
0
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 800 shares of Company stock on July 7, 2020 at prices ranging from $650.00 to $650.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 200 shares of Company stock on July 7, 2020 at prices ranging from $651.02 to $651.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 7, 2020 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**George L. Sing
2020-07-07